ProFibrix BV of the Netherlands, which is developing products to promote hemostasis after surgery, has completed a follow-on Series B financing with the support of new venture capital investors from Luxembourg and the Netherlands. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
